Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Malignant melanoma of the female genital tract diagnosed by cervicovaginal smear: A rare case from the Middle East. (PubMed, Cytojournal) - Oct 11, 2026 - "She is currently receiving adjuvant nivolumab and is doing well. To the best of our knowledge, melanoma diagnosed through cervicovaginal Pap smear has been rarely documented in a Middle Eastern woman. This case underscores the critical role of cytological screening and the importance of a broad differential diagnosis for detecting rare malignancies, even in low-incidence regions." 
Journal • Melanoma • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42856974
 
Ishaq Al Salmi; Nasser Al Rahbi; Waleed Al Amri
 
Oct 11, 2026
 
Prev Next